TheStreet’s Action Alerts PLUS Portfolio Manager and host of CNBC’s ‘Mad Money’ Jim Cramer commented on Caterpillar's (CAT) earnings report when answering viewers questions from social media on Thursday. Cramer said while Caterpillar's balance sheet has been fixed, the company has some difficult end markets such as oil, mining and construction. He added that Caterpillar is also levered to China. Still, Cramer said he thinks the dividend is safe, thanks to the balance sheet. Another viewer asked about stock of Nucor (NUE) ahead of its earnings. Cramer responded that it's the only steel company he would get in front of, with the exception of Reliance Steel (RS), but Cramer added the company is being eviscerated by Chinese dumping, something he'll be talking about more next week. Cramer was asked about Under Armour (UA), and he responded that investors should look at the growth of the company's Connected Fitness business, which is fantastic. He said if the stock comes in, buy it. McDonald's (MCD) was the subject of a viewer question. Cramer spoke highly of McDonald's CEO, calling Steve Easterbrook 'magnificent' and said the turn is real. On a side note, Cramer also said his favorite meal is an Egg McMuffin. You can send Jim Cramer questions on Facebook, and on Twitter, follow him @JimCramer and send questions using #CramerQ.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.